IL123623A0 - Processes and intermediates for preparing 1-(2-[2-Isoxazol-3-Ylbenzofuran-5-yloxy]ethylamino)-3-phenoxy-2(S)-OL - Google Patents

Processes and intermediates for preparing 1-(2-[2-Isoxazol-3-Ylbenzofuran-5-yloxy]ethylamino)-3-phenoxy-2(S)-OL

Info

Publication number
IL123623A0
IL123623A0 IL12362396A IL12362396A IL123623A0 IL 123623 A0 IL123623 A0 IL 123623A0 IL 12362396 A IL12362396 A IL 12362396A IL 12362396 A IL12362396 A IL 12362396A IL 123623 A0 IL123623 A0 IL 123623A0
Authority
IL
Israel
Prior art keywords
ylbenzofuran
isoxazol
yloxy
ethylamino
phenoxy
Prior art date
Application number
IL12362396A
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL123623A0 publication Critical patent/IL123623A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL12362396A 1995-10-31 1996-08-15 Processes and intermediates for preparing 1-(2-[2-Isoxazol-3-Ylbenzofuran-5-yloxy]ethylamino)-3-phenoxy-2(S)-OL IL123623A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US815395P 1995-10-31 1995-10-31
PCT/IB1996/000803 WO1997016432A1 (en) 1995-10-31 1996-08-15 Processes and intermediates for preparing 1-(2-[2-isoxazol-3-ylbenzofuran-5-yloxy]ethylamino)-3-phenoxy-2(s)-ol

Publications (1)

Publication Number Publication Date
IL123623A0 true IL123623A0 (en) 1998-10-30

Family

ID=21730067

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12362396A IL123623A0 (en) 1995-10-31 1996-08-15 Processes and intermediates for preparing 1-(2-[2-Isoxazol-3-Ylbenzofuran-5-yloxy]ethylamino)-3-phenoxy-2(S)-OL

Country Status (15)

Country Link
EP (1) EP0861240A1 (en)
JP (1) JPH10513480A (en)
KR (1) KR19990067172A (en)
CN (1) CN1201455A (en)
AU (1) AU6628596A (en)
BR (1) BR9611217A (en)
CA (1) CA2234081A1 (en)
CZ (1) CZ130898A3 (en)
HR (1) HRP960502A2 (en)
HU (1) HUP9900090A3 (en)
IL (1) IL123623A0 (en)
PL (1) PL327997A1 (en)
TR (1) TR199800710T2 (en)
WO (1) WO1997016432A1 (en)
YU (1) YU57396A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120253481A1 (en) * 2011-03-29 2012-10-04 General Electric Company Hart channel interface component including redundancy
EP2653464B1 (en) * 2012-04-20 2017-09-27 Rohm and Haas Company Benzylamine hydrophobe

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL312005A1 (en) * 1993-06-14 1996-04-01 Pfizer Binary amines as antidiabetic and antiobesitic agents

Also Published As

Publication number Publication date
WO1997016432A1 (en) 1997-05-09
PL327997A1 (en) 1999-01-04
CZ130898A3 (en) 1999-03-17
JPH10513480A (en) 1998-12-22
KR19990067172A (en) 1999-08-16
TR199800710T2 (en) 1998-08-21
EP0861240A1 (en) 1998-09-02
AU6628596A (en) 1997-05-22
HUP9900090A2 (en) 1999-10-28
CA2234081A1 (en) 1997-05-09
HRP960502A2 (en) 1998-04-30
MX9803497A (en) 1998-09-30
BR9611217A (en) 1999-04-06
CN1201455A (en) 1998-12-09
HUP9900090A3 (en) 1999-11-29
YU57396A (en) 1998-11-05

Similar Documents

Publication Publication Date Title
EP0754468A3 (en) Reusable blood lines
SG55098A1 (en) Naphthyl compounds intermediates compounds and methods
AU4237896A (en) Method and intermediates for the synthesis of korupensamines
AU1688295A (en) Method of personnel verification
EP0955905A4 (en) Surgical fastening system and method for using the same
IL118406A0 (en) Nasal applicator
IL114517A0 (en) Heart assist system
IL115538A0 (en) Method and system for determination of the pressure-volume relationship of the heart
EP0727869A4 (en) Booster
GB2298252B (en) Procedure for gearbox-type determination
GB9502267D0 (en) Muffler for booster
IL123623A0 (en) Processes and intermediates for preparing 1-(2-[2-Isoxazol-3-Ylbenzofuran-5-yloxy]ethylamino)-3-phenoxy-2(S)-OL
ZA96125B (en) Depilatory strips
IL117849A0 (en) Process for the purification of glycoproteins
EP0736296A3 (en) Coffin
GB2294100B (en) Booster
GB2288839B (en) Bridge
GB9410216D0 (en) Improvements relating to recognition system
PL318329A1 (en) Assisted braking system
EP0776646A4 (en) Wheelchair
PL324647A1 (en) Polyhydroxyalkyl amidobetains
GB2320071B (en) Booster
GB2309925B (en) Fixing method
GB9415896D0 (en) Dental system
ZA958700B (en) Stress application system